Results 151 to 160 of about 14,588,697 (257)

Clotting and other plasma factors in experimental endotoxemia: inhibition of degradation by exogenous proteinase inhibitors. [PDF]

, 1981
H. Schiessler, M. Jochum, H.K. Selbmann, G. Ruckdeschl, H. Fritz, Jochum, Marianne, Schießler, Hans, J. Witte, Fritz, Hans, Witte, J., Selbmann, H. K., Ruckdeschl, G.   +11 more
core   +1 more source

Effect of Russell\u27s viper venom and hydrogen peroxide on the clotting time of blood

, 2006
The clotting time of blood is a measure as to how long blood requires to transform from its liquid state to that of a solid. The final product of clotting is the production of a fibrin clot (scab), a three dimensional polymer.
Spillert, Charles R., Kapadia, Nimisha P.   +1 more
core  

Lanthanum Carbonate Nanosheets Based Colloidal Hydrogel for Modulating Innate & Adaptive Tumor Immunotherapy by Augmented Cellular Pyroptosis

Advanced Science, EarlyView.
The Gela/decitabine/La2(CO3)3 colloidal (GDLC) hydrogel developed here could reverse the epigenetic silencing of the GSDME gene by the synergistic interaction between DAC and La3+, while concurrently activating caspase‐3, thus facilitating pyroptosis induction under the tumor microenvironment.
Yang Hong, Haitao Wu, Weitao Wang, Xuan Zhang, Qian Chen, Yaoyu Hu, Zhengbao Zha   +6 more
wiley   +1 more source

Evaluation of Point-of-Care Coagulation Measurement Systems for Activated Clotting Time and Partial Thromboplastin Time in Heparinized and Non-Heparinized Equine Blood. [PDF]

J Vet Emerg Crit Care (San Antonio)
Hobbs KJ, Ueda Y, Qu Y, Cooper BL, Sheats MK, Burke MJ.   +5 more
europepmc   +1 more source

Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic Procedure. [PDF]

Diagnostics (Basel), 2023
Helin T, Tirri T, Korkala H, Lappalainen K, Joutsi-Korhonen L.   +4 more
europepmc   +1 more source

Engineered Xenogeneic Bone Scaffold with IL‐10 Nanodelivery System: Immunomodulation and BMSC Fate Programming for Skull Defect Repair

Advanced Science, EarlyView.
A multifunctional regenerative composite is constructed by 3D‐printing thermosensitive PNIPAM hydrogel embedded with MPDA@IL‐10 nanoparticles and autologous BMSCs onto antigen‐depleted porcine bone matrix for beagle critical‐sized skull defect reconstruction.
Weihao Lv, Lei Zhang, Fei Fei, Zhibin Wu, Xiuquan Wu, Ya‐nan Dou, Yihao Fu, Hao Chang, Yujie Qiang, Huaxia Xie, Ni An, Leiying Chen, Hongchen Zhang, Min‐Wen Zheng, Hongqing Chen, Xia Li, Zhou Fei   +16 more
wiley   +1 more source

Comparison of two algorithms of APTT-based lupus anticoagulant assay, two Dilute Russell viper venom time reagents, and silica clotting time. [PDF]

PLoS One
Wongkrajang P, Pientong T, Hanyongyuth R, Tientadakul P.   +3 more
europepmc   +1 more source

Comparison of Extracorporeal Life Support Anticoagulation Using Activated Clotting Time Only to a Multimodal Approach in Pediatric Patients. [PDF]

J Pediatr Pharmacol Ther, 2022
Galura G, Said SJ, Shah PA, Hissong AM, Chokshi NK, Fauman KR, Rose R, Bondi DS.   +7 more
europepmc   +1 more source

TRIM28‐Derived Peptide Exerts Anti‐Tumor Roles by Stabilizing Tumor Suppressive BRD7 Protein in Multiple Cancers

Advanced Science, EarlyView.
An α‐helical peptide, TAB12, designed to mimic the TRIM28 binding interface, competitively disrupts the TRIM28‐BRD7 interaction, thereby blocking ubiquitin‐mediated degradation of the tumor suppressor BRD7. This stabilization unleashes potent anti‐tumor effects across multiple tumor types with a favorable safety profile, offering a feasible strategy ...
Qingqing Wei, Changning Xue, Mengna Li, Jianxia Wei, Lemei Zheng, Shipeng Chen, Yijie Wang, Yumei Duan, Yanwei Luo, Wei Xiong, Ming Zhou   +10 more
wiley   +1 more source

Neither tranexamic acid nor ulinastatin affects the activated clotting time values in healthy volunteers and heparinized cardiovascular surgery patients. [PDF]

J Cardiothorac Surg
Jia B, Deng J, Yao Y, Evidence in Cardiovascular Anesthesia Group.   +3 more
europepmc   +1 more source